Table.3.
Association between histological response and ≥ 30% relative decline in MRI-PDFF
| Relative decline in MRI-PDFF | ≥ 30% vs < 30% relative decline in MRI-PDFF | ||||
|---|---|---|---|---|---|
|
| |||||
| Histologic response (≥ 1 point/stage decrease) | ≥ 30% (n = 25) | < 30% (n = 75) | Odds ratio | 95%CI | p value |
| Steatosis | 64% | 32% | 3.78 | 1.5-9.8 | 0.006 |
| Lobular inflammation | 44% | 24% | 2.49 | 0.9-6.4 | 0.06 |
| Ballooning | 56% | 41% | 1.81 | 0.7-4.5 | 0.2 |
| NAS response* | 60% | 24% | 4.75 | 1.8-12 | 0.001 |
| Fibrosis** | 50% | 21% | 3.75 | 1.2-12 | 0.03 |
NAS response is defined as ≥ 2 points improvement in NAS with no worsening of fibrosis.
Fibrosis response limits to patients with fibrosis stage 1-4 at baseline.
MRI, magnetic resonance imaging; PDFF, proton density fat fraction; NAS, nonalcoholic fatty liver disease activity score; CI, confidence interval